Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

ImmunoPET imaging to assess target engagement: Experience from Zr-89-anti-HER3 mAb (GSK2849330) in patients with solid tumors

Autor: Mcgeoch, A., van Oordt, C. Menke-van der Houven, Bergstrom, M., McSherry, I., Smith, D., Cleveland, M., Hoekstra, O., Vugts, D., Weber, A., Freedman, I., Huisman, M., Matheny, C., van Dongen, G., Zhang, S.

Publikováno v: Mcgeoch, A, van Oordt, C M D H, Bergstrom, M, McSherry, I, Smith, D, Cleveland, M, Hoekstra, O, Vugts, D, Weber, A, Freedman, I, Huisman, M, Matheny, C, van Dongen, G & Zhang, S 2017, ' ImmunoPET imaging to assess target engagement: Experience from Zr-89-anti-HER3 mAb (GSK2849330) in patients with solid tumors ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 44, pp. S314-S315 .
European Journal of Nuclear Medicine and Molecular Imaging, 44, S314-S315. Springer Verlag

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5ad133910de30e8336c151d1cb0becca
https://research.vumc.nl/en/publications/f11bd120-9eba-4c6f-abb8-44bef0532c71

1271P 4-year survival in randomised phase II (POPLAR) and phase III (OAK) studies of atezolizumab (atezo) vs docetaxel (doc) in pre-treated NSCLC

Autor: Mazieres, J., Rittmeyer, A., Gadgeel, S.M., Hida, T., Gandara, D., Cortinovis, D., Barlesi, F., Yu, W., Matheny, C., Ballinger, M., Park, K.

Publikováno v: In Annals of Oncology September 2020 31 Supplement 4:S821-S822

1117TiP - IMvoke010: Randomized phase III study of atezolizumab (atezo) as adjuvant monotherapy after definitive therapy of squamous cell carcinoma of the head and neck (SCCHN)

Autor: Haddad, R., Wong, D.J., Guo, Y., Fayette, J., Cohen, E.E.W., Kowgier, M., Sandler, A., Matheny, C., Kabbinavar, F., Raben, D.

Publikováno v: In Annals of Oncology October 2018 29 Supplement 8

MA 10.03 3-Year Survival and Duration of Response in Randomized Phase II Study of Atezolizumab vs Docetaxel in 2L/3L NSCLC (POPLAR)

Autor: Park, K., Lewanski, C., Gadgeel, S., Fehrenbacher, L., Mazieres, J., Rittmeyer, A., Han, J., Artal-Cortes, A., Braiteh, F., Gandhi, M., Yu, W., Matheny, C., He, P., Sandler, A., Ballinger, M., Vansteenkiste, J.

Publikováno v: In Journal of Thoracic Oncology November 2017 12(11) Supplement 2:S1840-S1840